Follow-up study of unknowingly pregnant women vaccinated against Rubella in Brazil, 2001-2002

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 2, 2011, Pages

  Soares, Rosa Castalia ^a,m   Siqueira, Marilda M ^d   Toscano, Cristiana Maria ^c,n   De Lourdes S Maia, Maria ^a,o   Flannery, Brendan ^c   Sato, Helena K ^g   Will, Rosane M ^h   Rodrigues, Regina C M ⁱ   Oliveira, Imaculada C ⁱ   Barbosa, Tânia Cristina ^f   Sa G R S ^e,f   Rego, Marta Ferreira ^h   Curti, Sueli P ^g   Lemos, Xênia R ^d   Morhdieck, Renate ^j   Stürmer, Denise ^j   Oliveira, Maria José C ^k   Da Silva Junior, Jarbas Barbosa ^a,m   Castillo Solórzano, Carlos ^l   Camacho, Luiz A B ^e   Luna, Expedito ^b,p   more..

^a Apto 601   (Brazil)

^b Secretariat of Public Health Surveillance   (Brazil)

^c PAN AMERICAN HEALTH ORGANIZATION   (Brazil)

^d Measles and Respiratory Viruses Laboratory   (Brazil)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f Department of Rio de Janeiro State Health ^*  (Brazil)

^g INSTITUTO ADOLFO LUTZ   (Brazil)

^h Medical and Public Health   (Brazil)

ⁱ Health State Office of Minas Gerais   (Brazil)

^j Central Public Health Laboratory   (Brazil)

^k Central Public Health Laboratory   (Brazil)

^l PAN AMERICAN HEALTH ORGANIZATION   (United States)

^m MINISTÉRIO DA SAÚDE   (Brazil)

ⁿ FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^o Instituto de Technologia em Imunobiologicos   (Brazil)

^p UNIVERSITY OF SÃO PAULO   (Brazil)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; RUBELLA ANTIBODY; RUBELLA VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ARTICLE; BAHIA; BRAZIL; CHILD; CONGENITAL RUBELLA SYNDROME; DELIVERY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FETUS MONITORING; FETUS OUTCOME; FOLLOW UP; GOIAS; HEALTH SURVEY; HUMAN; IMMUNOASSAY; INCIDENCE; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MASS IMMUNIZATION; MINAS GERIAS; PERNAMBUCO; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; RIO DE JANEIRO; RIO GRANDE DO SUL; RISK ASSESSMENT; RUBELLA; RUBELLA VIRUS; SAO PAULO; VIRUS SHEDDING; BLOOD SAMPLING; DISEASE SURVEILLANCE; LIVE BIRTH; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; REVIEW;

EID: 80053406372     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir429     Document Type: Article

References (25)

1. Cooper L, Krugman S. Clinical manifestation of postnatal and congenital rubella. Arch Ophthalmol 1967; 77:434-7.
2. Miller E, Cradock-Watson JE, Pollock TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2:781-4. (Pubitemid 12068990)
3. Pan American Health Organization. Resolution CD44.R1: sustaining immunization programs-elimination of rubella and congenital rubella syndrome. Washington, DC: PAHO, 2003.
4. Fonseca S, Dantas V, Dantas M, Fernandes J. Avaliacxão do estado imune de mulheres em idade reprodutiva em relacxão ao vírus da rube ola. Rev Bras Ginecol Obstet 1999; 21:261-6.
5. Rey LC, Barbosa LM, Osterno CL, et al. Inquérito soroló gico de rubéola na era pré-vacinacão em creches, escolas e maternidades de Fortaleza. J Pediatr (Rio J) 1998; 74:467-72.
6. Bolognese R, Corson S, Fuccillo D, et al. Evaluation of possible transplacental infection with rubella vaccination during pregnancy. Am J Obst Gynecol 1973; 117:939-41.
7. FleetWF Jr, Benz EWJr, Karzon DT, Lefkowitz LB, Herrmann KL. Fetal consequences of maternal rubella immunization. JAMA 1974; 227:621-7.
8. Modlin JF, Herrmann K, Brandling-Bennett AD, Eddins DL, Hayden GF. Risk of congenital abnormality after inadvertent rubella vaccination of pregnant women. N Engl J Med 1976; 294:972-4.
9. Vaheri A, Vesikari T, Oker-Blom N, et al. Transmission of attenuated rubella vaccines to the human fetus: a preliminary report. Am J Dis Child 1969; 118:243-6.
10. Centers for Disease Control and Prevention. Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep 2001; 50:1117.
11. Enders G. Rubella antibody titers in vaccinated and nonvaccinated women and results of vaccination during pregnancy. Rev Infect Dis 1985; 7(Suppl 1):S103-7.
12. Tookey PA, Jones G, Miller BH, Peckham CS. Rubella vaccination in pregnancy. CDR (Lond Engl Rev) 1991; 1:R86-8.
13. National Immunization Program. Technical bulletin for the rubella vaccination campaign among women of childbearing age. In: National Health Department, ed. Brasilia, Brazil: Ministry of Health 2001.
14. Bosma TJ, Corbett KM, O'Shea S, Banatvala JE, Best JM. PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol 1995; 33:1075-9.
15. Donadio FF, Siqueira MM, Vyse A, Jin L, Oliveira SA. The genomic analysis of rubella virus detected from outbreak and sporadic cases in Rio de Janeiro state, Brazil. J Clin Virol 2003; 27:205-9. (Pubitemid 37329342)
16. Cooray S, Warrener L, Jin L. Improved RT-PCR for the diagnosis and epidemiological surveillance of rubella. J Clin Virol 2006; 35:73-80. (Pubitemid 43020956)
17. World Health Organization. Guidelines for surveillance of congenital rubella syndrome and rubella: field test version. Geneva, Switzerland: WHO, 1999.
18. Bar-Oz B, Levichek Z, Moretti ME, Mah C, Andreou S, Koren G. Pregnancy outcome following rubella vaccination: a prospective controlled study. Am J Med Genet A 2004; 130:52-4. (Pubitemid 39121561)
19. Hamkar R, Jalilvand S, Abdolbaghi MH, et al. Inadvertent rubella vaccination of pregnant women: evaluation of possible transplacental infection with rubella vaccine. Vaccine 2006; 24:3558-63.
20. Vial P, Foradori A, BecerraM, et al. Evaluation of 3 laboratory methods for the serological diagnosis of rubella. Rev Med Chil 1986; 114:445-9.
21. Badilla X, Morice A, Avila-Aguero ML, et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr InfectDis J 2007; 26:830-5. (Pubitemid 47329856)
22. Suzano CE, Amaral E, Sato HK, Papaiordanou PM. The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil. Vaccine 2006; 24:1421-6. (Pubitemid 43222053)
23. Schramm JM, Szwarcwald CL. Hospital system as a source of information to estimate stillbirth and neonatal mortality rates. Rev Saude Publica 2000; 34:272-9.
24. Castillo-Solórzano C, Carrasco P, Tambini G, Reef S, Brana M, de Quadros CA. New horizons in the control of rubella and prevention of congenital rubella syndrome in the Americas. J Infect Dis 2003; 187(Suppl 1):S146-52.
25. Maia M, Silva J, Soares R, et al. Brazil accelerates control and prevention of congenital rubella syndrome. EPI Newsl 2002; 24:1-3. http://new.paho.org. Accessed 1 August 2011.